Pliant Therapeutics
PLRX
PLRX
136 hedge funds and large institutions have $1.04B invested in Pliant Therapeutics in 2023 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 52 increasing their positions, 34 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
1% less capital invested
Capital invested by funds: $1.05B → $1.04B (-$9.48M)
6% less funds holding
Funds holding: 144 → 136 (-8)
25% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 28
Holders
136
Holding in Top 10
8
Calls
$2.87M
Puts
$1.96M
Top Buyers
| 1 | +$25.1M | |
| 2 | +$19.5M | |
| 3 | +$6.6M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$6.45M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.64M |
Top Sellers
| 1 | -$16.6M | |
| 2 | -$8.26M | |
| 3 | -$6.41M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5.29M |
| 5 |
Two Sigma Investments
New York
|
-$3.76M |